Clinical Trial Update: Evaluation of Manufacturing Lot of StaphVAX [Phase 3]

View source ↗

Summary

Phase 3 trial update describing evaluation of a manufacturing lot for StaphVAX; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Staphylococcal Infections

Drugs mentioned

• StaphVAX

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Staphylococcal Infections, Chronic Kidney Failure | Phase 3 | Status: COMPLETED